D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Booking.com
BKNG
|
+$634M |
| 2 |
Charles Schwab
SCHW
|
+$431M |
| 3 |
Walmart
WMT
|
+$421M |
| 4 |
Visa
V
|
+$400M |
| 5 |
Johnson & Johnson
JNJ
|
+$322M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$546M |
| 2 |
Salesforce
CRM
|
+$449M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$392M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$364M |
| 5 |
GE Aerospace
GE
|
+$345M |
Sector Composition
| 1 | Technology | 21.77% |
| 2 | Consumer Discretionary | 13.79% |
| 3 | Healthcare | 12.86% |
| 4 | Financials | 11.91% |
| 5 | Industrials | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Vaxcyte
PCVX
$4.25B
| $29.8M | 0.03% |
794,907
-177,414
| -18% | -$6.65M |
|
377
Kyndryl
KD
$7.66B
| $29.7M | 0.03% |
2,015,051
+331,617
| +20% | +$4.89M |
|
378
Tyler Technologies
TYL
$24.2B
| $29.6M | 0.03% |
83,516
+10,968
| +15% | +$3.89M |
|
379
Hyatt Hotels
H
$13.8B
| $29.5M | 0.03% |
263,864
+120,275
| +84% | +$13.4M |
|
380
Philip Morris
PM
$256B
| $29.5M | 0.03% |
303,093
+23,403
| +8% | +$2.28M |
|
381
Ollie's Bargain Outlet
OLLI
$7.85B
| $29.2M | 0.03% |
503,497
+308,971
| +159% | +$17.9M |
|
382
Nike
NKE
$109B
| $29.1M | 0.03% |
237,642
-776,319
| -77% | -$95.2M |
|
|
NVRO
383
DELISTED
NEVRO CORP.
NVRO
| $29M | 0.03% |
802,595
+209,296
| +35% | +$7.57M |
|
384
Alcon
ALC
$39B
| $28.9M | 0.03% |
409,413
+401,094
| +4,821% | +$28.3M |
|
385
Skyworks Solutions
SWKS
$11.1B
| $28.7M | 0.03% |
243,524
-900,581
| -79% | -$106M |
|
386
Advanced Drainage Systems
WMS
$10.7B
| $28.4M | 0.03% |
336,739
-39,710
| -11% | -$3.34M |
|
387
Medpace
MEDP
$13.6B
| $28.3M | 0.03% |
150,390
+7,861
| +6% | +$1.48M |
|
388
Paylocity
PCTY
$9.49B
| $28M | 0.03% |
140,670
+70,392
| +100% | +$14M |
|
389
Gen Digital
GEN
$18.1B
| $27.7M | 0.03% |
1,613,506
+737,728
| +84% | +$12.7M |
|
|
ITCI
390
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $27.6M | 0.03% |
509,904
-3,596
| -0.7% | -$195K |
|
391
Mobileye
MBLY
$12.1B
| $27.6M | 0.03% |
637,003
+244,962
| +62% | +$10.6M |
|
392
HCA Healthcare
HCA
$96.7B
| $27.6M | 0.03% |
104,527
+39,125
| +60% | +$10.3M |
|
393
Sally Beauty Holdings
SBH
$1.45B
| $27.3M | 0.03% |
1,753,760
+478,506
| +38% | +$7.46M |
|
394
Apellis Pharmaceuticals
APLS
$3.39B
| $27.2M | 0.03% |
412,853
+399,955
| +3,101% | +$26.4M |
|
395
Travel + Leisure Co
TNL
$4.04B
| $27.2M | 0.03% |
693,693
-206,353
| -23% | -$8.09M |
|
396
GameStop
GME
$10.6B
| $27.2M | 0.03% |
+1,180,737
| New | +$27.2M |
|
397
ADMA Biologics
ADMA
$3.91B
| $27.2M | 0.03% |
8,211,573
-296,836
| -3% | -$983K |
|
398
Mohawk Industries
MHK
$8.42B
| $27.1M | 0.03% |
269,953
-21,422
| -7% | -$2.15M |
|
399
Ovintiv
OVV
$10.7B
| $27M | 0.03% |
748,062
-210,918
| -22% | -$7.61M |
|
400
Carrier Global
CARR
$54B
| $26.8M | 0.03% |
584,990
-413,506
| -41% | -$18.9M |
|